Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAD Study of SYN-020 in Healthy Subjects
NCT04815993Phase 1Completed
- Sponsor
- Theriva Biologics
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Small Molecules, Replacement Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of intestinal alkaline phosphatase in radiation enteritis (4 arms), sponsored by Theriva Biologics. Primary endpoints: SYN-020 systemic absorption at Day 5 and SYN-020 presence in feces at Day 6. Started Mar 2021; status: completed.
02
Drugs
intestinal alkaline phosphatase
03
Conditions
radiation enteritis
Beyond the preview
Go deeper on NCT04815993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815993.